BRAF MUTATION-RELATED TUMORS
Clinical trials for BRAF MUTATION-RELATED TUMORS explained in plain language.
Never miss a new study
Get alerted when new BRAF MUTATION-RELATED TUMORS trials appear
Sign up with your email to follow new studies for BRAF MUTATION-RELATED TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for rare thyroid cancer in early trial
Disease control Recruiting nowThis early-phase study tests whether giving two drugs (XL092 and cemiplimab) before surgery can help remove a rare and fast-growing thyroid cancer called anaplastic thyroid cancer. The study includes 12 adults whose cancer has a specific gene change (BRAF V600E). The main goals a…
Matched conditions: BRAF MUTATION-RELATED TUMORS
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New pill targets hard-to-treat cancers with KRAS and BRAF mutations
Disease control Recruiting nowThis early-phase study tests an oral drug called S241656 in adults with advanced cancers that have certain gene changes (KRAS, BRAF, and others). The drug is given alone or with other cancer treatments. The goal is to find safe doses and see if the drug shrinks tumors. About 554 …
Matched conditions: BRAF MUTATION-RELATED TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control
Last updated May 12, 2026 13:40 UTC